• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, March 4, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Vaccine confidence grows under new administration, latest CUNY SPH Survey reveals

Bioengineer by Bioengineer
February 9, 2021
in Immunology
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: CUNY SPH

Under the Biden Administration, New Yorkers’ acceptance of the Covid-19 vaccine has increased significantly. In September, 55% of residents reported they would take the vaccine when it became available and this January, 64% reported they would take it.

Differences in vaccine acceptance persist across racial and ethnic groups. Among Whites and Asians acceptance is 70-72%; among Blacks and Latina/os it is 57-58%. On a positive note, the largest increase in rate of acceptance was seen among Black respondents, up from 33% in September to 57% in January.

These are key findings from the most recent tracking survey of public perceptions and experiences in New York City during the Covid-19 pandemic, conducted January 29-31 by the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH).

“Obtaining a steady supply of Covid-19 vaccines and distributing them equitably and efficiently, as well as reaching and convincing New Yorkers to take the vaccine are the pivotal challenges that lie ahead of us,” said Dr. Ayman El-Mohandes, Dean of CUNY SPH. “The current strategy does not meet the needs of those with the greatest vulnerability.”

Of concern, more than half (54%) of New York City respondents believe the state is not doing a good job of managing the vaccine rollout. Highest levels of disapproval were reported by Staten Island (59%) the Bronx (50%) and Manhattan (50%).

Almost half of New York City residents think that recovery will not happen until most New Yorkers are vaccinated. In contrast, only 53% of residents in the Bronx are willing to take the vaccine. This finding is of great concern, since the Bronx continues to bear the highest burden of infection and mortality associated with the pandemic.

Employment and Covid-19 Vaccine Acceptance

Respondents who are currently employed were more willing to accept Covid-19 vaccines (68%) as well as more likely to actually have been vaccinated. Among respondents who lost their job during the pandemic and remain unemployed, only 56% said they were willing to accept the vaccine.

These data suggest that a concerted effort will be needed to reach, inform, and motivate unemployed New York City residents to participate in the vaccination rollout.

The complete survey results and related commentary can be found at https://sph.cuny.edu/research/covid-19-tracking-survey/january-vaccines/ and JHC Impact, an initiative of the Journal of Health Communication: International Perspectives.

Methodology

The CUNY Graduate School of Public Health and Health Policy (CUNY SPH) survey was the third study of a repeated cross sectional sample using n=1,000 New York City residents from January 29-31, 2021, the previous two surveys were conducted at the end of September and November 2020.

The representative area-based probability sample for New York City was n=1,000, with a margin of error (MOE) of +/- 3 percentage points. The data set was weighted by gender, age, ethnicity, education, and borough based on the 2019 1-year American Community Survey model. Additional considerations beyond the ACS model influenced weights for race/ethnicity as the Census Bureau collects two sets of race/ethnicity data by grouping Hispanics and races together (e.g., Hispanic Whites) as well as separating non-Hispanic and Hispanic groups. To create one data set that more appropriately represents the racial diversity in the city, we grouped Hispanic and Latina/os respondents together. It is important to remember that subsets based on gender, age, ethnicity, and region carry with them higher margins of error, as the sample size is reduced.

Sampling parameters were set based borough-level population data:

  • Queens: 27% of total (n=271)
  • Manhattan: 19% of total (n=194)
  • The Bronx: 17% of total (n=171)
  • Staten Island: 5% of total (n=57)
  • Brooklyn: 31% of total (n=308)

The data was collected by Consensus Strategies using an Interactive Voice Response (IVR) system of landlines (n=511), SMS-to-online (n=490).

Demographics:

1,001 Residents NYC

Age

18-19 23%

30-44 28%

45-59 24%

60+ 26%

Gender

Male 46%

Female 50%

Prefer not to say 2%

Other 1%

Race and ethnicity

Latina/o/Hispanic 29%

Black/African American 22%

Asian 14%

Caucasian/White 32%

Multiple/other 3%

Education Level

High school 42%

Some college 20%

Bachelor’s 22%

Post-grad 16%

Household Income

$50,000-$100,000 30%

>$100,000 13%

###

Media Contact
Ariana Costakes
[email protected]

Original Source

https://sph.cuny.edu/research/covid-19-tracking-survey/january-vaccines/

Tags: Infectious/Emerging DiseasesMedicine/HealthPublic HealthVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

COVID-19 can kill heart muscle cells, interfere with contraction

March 2, 2021
IMAGE

Repurposed arthritis drug did not significantly improve severe COVID-19 pneumonia

March 1, 2021

Balanced T cell response key to avoiding COVID-19 symptoms, study suggests

March 1, 2021

Covid-19: How to do lockdown? Russian scientists may have an answer

March 1, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    665 shares
    Share 266 Tweet 166
  • People living with HIV face premature heart disease and barriers to care

    83 shares
    Share 33 Tweet 21
  • Global analysis suggests COVID-19 is seasonal

    38 shares
    Share 15 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Cell BiologyTechnology/Engineering/Computer SciencePublic HealthEcology/EnvironmentInfectious/Emerging DiseasescancerBiologyMedicine/HealthClimate ChangeGeneticsMaterialsChemistry/Physics/Materials Sciences

Recent Posts

  • Research contributes to understanding of hypersonic flow
  • New microcomb could help discover exoplanets and detect diseases
  • Purdue Research Foundation partners with IdentifySensors Biologics for COVID-19 technology
  • Air pollution fell sharply during lockdown
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In